Each year, MNGI Digestive Health tracks and reports on key colonoscopy quality measures for our gastroenterologists. The recently released 2024 Adenoma Detection Rate (ADR) data highlights the exceptional performance of MNGI physicians in identifying and removing precancerous polyps during screening colonoscopies for patients aged 45 and older.
The results are remarkable: MNGI’s average ADR is 68.4% for male patients and 57.5% for female patients, significantly exceeding the national performance targets of 30% for males and 20% for females set by the American Society for Gastrointestinal Endoscopy (ASGE). This means MNGI’s ADR is more than double the benchmark for men and nearly triple the benchmark for women.
Higher ADRs are directly linked to a reduced risk of developing colorectal cancer within 5 to 10 years following a colonoscopy. By choosing MNGI for your screening colonoscopy, you are making a proactive decision to lower your risk and prioritize your health.
Trust the experts at MNGI for your next screening colonoscopy. Learn more about ADR and other quality measures on the Quality & Outcomes section of our About Us page.
